Add BrightSurf on Google Email

Novel possibility to stop dementia progression?

Researchers at the University of Helsinki discovered a potential treatment for Alzheimer's disease and frontotemporal dementia using a PREP inhibitor. The PREP inhibitor reduced Tau accumulation and toxicity in cellular models and mice with tauopathy, improving cognitive skills.

SourceUniversity of Helsinki·JournalScience Translational Medicine·TypeRandomized controlled/clinical trial·DateApr 12, 2023

Spike protein implicated in post-COVID-19 memory loss, Brazilian study finds

A recent Brazilian study found that the Spike protein from SARS-CoV-2 is implicated in post-COVID-19 memory loss, with researchers identifying TLR4 receptor as a potential therapeutic target. The study involved experiments with mice and showed that infusion of the Spike protein induced delayed memory impairment.

Psychedelics and Cognition: A New Look

A recent renaissance in psychedelic research investigates the cognitive effects of these drugs, shifting from mathematical modeling to behavioral and clinical studies. Studies have found that psychedelics can increase spontaneous creative insights while decreasing task-specific creativity, as well as affect memories in a malleable way.

World first: Researchers identify specific regions of the brain that are damaged by high blood pressure and are involved in a decline in mental processes and dementia

High blood pressure damages specific brain regions, including the putamen and white matter areas, leading to cognitive decline and increased risk of dementia. The study uses a combination of MRI, genetic analyses, and observational data to identify these affected regions.

SourceEuropean Society of Cardiology·JournalEuropean Heart Journal·TypeObservational study·DateMar 27, 2023

Insomnia, sleep apnea contribute to reports of cognitive decline in women with multiple sclerosis

Researchers found that women with multiple sclerosis were more likely to report sleep disorders, including obstructive sleep apnea, insomnia, and sleepiness. Insomnia mediated more than 10% of the cognitive problems reported by women with MS, while sleep apnea accounted for 34%.

SourceMichigan Medicine - University of Michigan·JournalMultiple Sclerosis Journal·TypeObservational study·DateMar 21, 2023

How neuroimaging can be better utilized to yield diagnostic information about individuals

Researchers from Dartmouth and University Medicine Essen found that strong links between brain measures and traits can be obtained when machine learning algorithms are utilized. This approach allows for high-powered results from moderate sample sizes, opening up studies of many traits and clinical conditions previously inaccessible.

SourceDartmouth College·JournalNature·TypeCommentary/editorial·DateMar 14, 2023

COVID-19 can cause 'face blindness'

A Dartmouth study found that COVID-19 can cause 'prosopagnosia,' or face blindness, and impairments in navigational abilities. Researchers worked with a patient who experienced difficulty recognizing faces and navigating, leading to dissociation between face recognition and cognitive map representation.

SourceDartmouth College·JournalCortex·TypeCase study·DateMar 13, 2023

A blood factor involved in depression

Researchers discovered that administration of GDF11 improves cognitive abilities and reduces depression-like behaviors in aged mice. In humans, low levels of GDF11 are associated with depressive episodes, suggesting a potential link between the protein and mood disorders.

SourceInstitut Pasteur·JournalNature Aging·TypeExperimental study·DateMar 2, 2023

Any regular physical activity at any age linked to better brain function in later life

A long-term study found that regular leisure time physical activity at any age is associated with better brain function in later life. Maintaining an exercise routine throughout adulthood was particularly beneficial for preserving mental acuity and memory. The study, which included over 1,400 participants, showed that being physically ...

SourceBMJ Group·JournalJournal of Neurology Neurosurgery & Psychiatry·TypeObservational study·DateFeb 21, 2023

Kessler Foundation team to study impact of strategy-based cognitive training on new learning and memory in individuals with multiple sclerosis

Researchers at Kessler Foundation are conducting a double-blind randomized clinical trial to evaluate the impact of their strategy-based cognitive training program on new learning and memory in individuals with multiple sclerosis. The study aims to assess the efficacy of this protocol, which is based on the KF-STEM protocol.

SourceKessler Foundation·JournalContemporary Clinical Trials Communications·TypeRandomized controlled/clinical trial·DateFeb 1, 2023

An action plan to prevent Alzheimer’s disease

An international task force led by UNIGE and HUG has developed a preventive protocol to address the growing number of people affected by Alzheimer's disease. The guidelines focus on four pillars: risk assessment, risk communication, risk reduction, and cognitive enhancement.

SourceUniversité de Genève·JournalThe Lancet Regional Health - Europe·TypeNews article·DateJan 31, 2023

More steps, moderate physical activity cuts dementia, cognitive impairment risk

A new study led by the University of California San Diego found that daily walking and moderate-to-vigorous physical activity significantly reduced the risk of developing mild cognitive impairment or dementia in senior women. With each additional 1,865 steps per day, the risk was lowered by 33%, while moderate-to-vigorous physical acti...

SourceUniversity of California - San Diego·JournalAlzheimer s & Dementia·TypeObservational study·DateJan 25, 2023

New smartphone app designed by University of Toronto researchers shown to significantly improve memory recall

Researchers developed HippoCamera, a new smartphone app that significantly improves memory recall by boosting attention to daily events. Users record videos and audio descriptions of everyday experiences, which are then replayed to reinforce memory consolidation.

SourceUniversity of Toronto·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 16, 2023

New findings on memory impairment in epilepsy

Researchers at the University of Bonn discovered that people with chronic epilepsy may have impaired dendritic integration, leading to less specific place cell firing and reduced ability to distinguish familiar from unfamiliar places. Administering a sodium ion channel inhibitor improved memory in animal models.

SourceUniversity of Bonn·JournalBrain·DateDec 19, 2022

A potential screening method to support drug development for dementia treatment featured in the December issue of SLAS Discovery

A new neuronal cell-based reporter system has been developed to identify compounds that inhibit histone deacetylase 2 (HDAC2) with minimal effect on its partner enzyme HDAC1. This innovation holds promise for dementia drug development by targeting the root cause of memory impairment.

SourceSLAS (Society for Laboratory Automation and Screening)·JournalSLAS DISCOVERY·TypeExperimental study·DateDec 14, 2022

Crossword puzzles beat computer video games in slowing memory loss

A new study published in NEJM Evidence found that crossword puzzle training significantly improved cognitive function and daily activities, reducing brain shrinkage in individuals with mild cognitive impairment. The findings suggest that engaging with familiar activities like crossword puzzles may be more effective than computerized co...

SourceColumbia University Irving Medical Center·JournalNEJM Evidence·TypeRandomized controlled/clinical trial·DateOct 27, 2022

Unlocking the power of our emotional memory

Researchers at Boston University have found a way to manipulate emotional memories using optogenetics, allowing them to rewrite and reduce the potency of negative memories. The study reveals that positive and negative memories are stored in distinct regions of the brain and communicate through different pathways.

SourceBoston University·JournalCommunications Biology·TypeExperimental study·DateOct 3, 2022

Two birds one stone strategy to treat both joint pain and cognitive impairment in rheumatoid arthritis

A study found that aberrant expression of MAO-B causes both peripheral and neuroinflammation in RA patients, leading to joint pain and cognitive impairment. Administering an MAO-B inhibitor called KDS2010 improved both joint inflammation and cognitive function in a RA animal model.

SourceInstitute for Basic Science·JournalExperimental & Molecular Medicine·TypeExperimental study·DateSep 28, 2022

COVID-19 infections increase risk of long-term brain problems

New research shows that COVID-19 infections can lead to a range of neurological complications in the first year after infection, including strokes, cognitive decline, depression, anxiety, and migraine headaches. The study analyzed over 14 million medical records and found that COVID-19 survivors were at increased risk of developing the...

SourceWashington University in St. Louis·JournalNature Medicine·TypeData/statistical analysis·DateSep 22, 2022

How fear memories get stuck in some brains

Researchers at Linköping University discovered a biological mechanism that increases the strength of fear memories stored in the brain. This finding provides new knowledge on the mechanisms behind anxiety-related disorders and identifies shared mechanisms with alcohol dependence.

SourceLinköping University·JournalMolecular Psychiatry·TypeExperimental study·DateSep 20, 2022